P rogrammed cell death, also known as apoptosis, occurs in a wide variety of cardiovascular disorders and is now recognized as a fundamental process that contributes to deterioration of cardiac function. 1 Controlling myocardial cell loss by enhancing survival signal cascades leading to inhibition of apoptosis could be a useful strategy for slowing development of heart failure. Among numerous signaling pathways involved in regulation of cell survival cascades, the serine-threonine kinase Akt/PKB plays a crucial role. 2, 3 Cytosolic Akt is activated by phosphorylation mediated by PI3-kinase and 3-phosphoinositide-dependent kinase (PDK) that are stimulated by growth factors such as IGF-1 at cell membrane. 4 -7 After activation, Akt accumulates in the nucleus, phosphorylates multiple protein substrates, and is thought to regulate gene transcription. 8 -19 Akt activation also promotes glucose transport, 20 glycogen 21 and protein 22, 23 synthesis, and withdrawal from the cell cycle. 24, 25 However, cardiovascular-related Akt research has been predominantly fueled by the ability of activated Akt to enhance cell survival by promoting signaling cascades that lead to inhibition of cardiomyocyte apoptosis in vitro 26 -28 and in vivo. 26, 29, 30 Akt-associated pathways and substrate proteins leading to antiapoptotic effects and cellular survival are complex, but recent studies suggest that biologically relevant targets of phospho-Akt action are localized in the nucleus. 8 -16 We previously reported a 2-fold higher level of phospho-Akt in cardiomyocyte nuclei of premenopausal women relative to men or postmenopausal women, and that estrogenic stimulation promotes accumulation of activated Akt in the nucleus. 31 Higher levels of nuclear Akt activity in women and in estrogen-treated cardiomyocytes could partially account for the gender-associated differential in development of heart failure in women compared with middle-aged men. 32 Protection from apoptotic stimuli in cardiomyocytes has been demonstrated using adenovirally mediated gene transfer of constitutively activated (myristolated) Akt. 26 -30 However, the constitutively activated form of Akt preferentially localizes at the cell membrane, resulting in supraphysiological levels of kinase activity. [33] [34] [35] Constitutively activated forms of PI3-kinase or Akt induce oncogenic transformation in fibroblasts, 35 as well as cardiac hypertrophy and/or failure, 36 -40 raising issues of feasibility and safety concerning the utility of Akt for therapeutic treatment of heart disease.
Antiapoptotic therapy for cardiomyocytes depends on successful inhibition of cell death without promoting activation of compensatory pathways leading to deleterious hypertrophic remodeling or cellular growth. Because biologically relevant target proteins of Akt kinase associated with inhibition of apoptosis may be localized in the nucleus, 8 -15,34 we explored the hypothesis that protection could be mediated by a nuclear-targeted Akt protein construct (Akt/nuc). Our results demonstrate the cytoprotective effects of Akt/nuc and support the potential interventional use of Akt/nuc as interventional treatment to combat apoptosis leading to heart failure.
Materials and Methods
Experimental methods are detailed in the expanded Materials and Methods in the online data supplement (available at http://circres. ahajournals.org). Briefly, an adenovirus expressing mouse cellular Akt upstream of nuclear localization signals (Akt/nuc) was created by PCR-based cloning technique with AdMax (MicroBix) Cremediated site-specific recombination system. Cell culture, immunohistochemistry and confocal microscopy, nuclear extract and cytosol preparation, immunoblot and kinase assays were previously described. 31 In vitro apoptosis was induced by staurosoprine, 2-deoxyglucose, or hypoxia and was quantified by TUNEL staining or PARP cleavage detection. The transgene for creation of nucleartargeted Akt mice was created by subcloning nuclear-targeted Akt cDNA construct downstream of the mouse ␣-myosin heavy chain gene promoter. The mouse model of myocardial infarction and quantification of infarct area have been previously described. 49 Microarray analysis was performed by using oligonucleotide microarray chips containing 70 mer probes for 16 463 mouse genes.
Results

Construction of Nuclear-Targeted Akt Adenovirus and Verification of Expression
Akt was targeted to the nucleus by cloning full-length wild-type mouse Akt cDNA upstream of three in-frame nuclear localization signal (NLS) sequences. Akt/nuc protein was distinguished from endogenous Akt by a 3Ј myc-tag ( Figure 1A ). The combined Akt-NLS-myc was subsequently subcloned into an adenoviral expression vector for efficient introduction of Akt/nuc into cardiomyocytes. Infection of neonatal rat cardiomyocyte cultures leads to nuclear accumulation of the adenovirally encoded Akt/nuc as demonstrated by both confocal microscopy ( Figure 1B ) and immunoblot with anti-myc antibody ( Figure 1C ).
Phosphorylated Akt/nuc Accumulates in the Nucleus of Infected Cardiomyocytes
Localization of phospho-Akt 308 was performed on infected cardiomyocytes to determine the phosphorylation status of Akt at residue T 308 corresponding to activation. 2, 3 Accumulation of Akt/nuc signal was confirmed by confocal microscopy of infected cardiomyocytes labeled with anti-Akt antibody ( Figures 1D3 and 1D4 ) versus cells expressing nuclear localized ␤-gal as a negative control ( Figures 1D1 and 1D2) . Comparably prepared cells labeled with anti-phospho-Akt 308 antibody also show nuclear immunoreactivity (Figures 1D6 and 1D7; green), consistent with activation of the adenovirally encoded Akt/nuc. In comparison, infection with either Akt/wt or Akt/myr resulted in predominantly cytosolic and/or membrane-associated Akt immunoreactivity with minimal nuclear labeling (data not shown).
Nuclear Extracts Show Elevation of Akt and Phospho-Akt After Infection With Akt/nuc Adenovirus
Nuclear accumulation of Akt/nuc prompted quantitative analysis to compare levels of Akt and phospho-Akt between . Signal intensities were standardized relative to histone protein to compensate for minor variations in protein loading (not shown). F, Akt/nuc kinase exhibits phosphorylation activity. Substrate phosphorylation assay for Akt kinase using nuclear extracts prepared from cultured neonatal rat cardiomyocytes infected with adenoviruses producing ␤-gal (control) or Akt/nuc. Immunoblot analysis shows Akt activity measured by phosphorylation of a GSK substrate detected by binding of antiphospho-GSK (p-GSK) antibody.
cardiomyocyte cultures expressing Akt/nuc versus adenovirus encoding nuclear-localized ␤-gal as a control for nonspecific effects. Nuclear-enriched fractions were prepared and subjected to immunoblot analysis using antibodies to total Akt as well as phosphorylation-specific antibodies directed against sites T 308 and S 473 that correlate with Akt activation (Figures 1E). Total Akt level in nucleus was substantially higher in Akt/nuc-expressing cultures compared with ␤-gal (64.2Ϯ21.9-fold). The same extracts also showed increases for both phospho-Akt 308 and phospho-Akt 473 level (2.0Ϯ0.4-and 4.5Ϯ1.4-fold, respectively) compared with ␤-gal expressing cardiomyocytes. All of the observed increases in Akt and phospho-Akt signal resulting from expression of Akt/nuc were highly significant (PϽ0.01).
Akt/nuc Increases Kinase Activity in the Nucleus
Phosphorylation of Akt correlates with kinase activation, so substrate phosphorylation analysis was performed on nuclear extracts of Akt/nuc-expressing cardiomyocyte cultures to confirm elevation of kinase activity. Akt kinase activity in immunoprecipitates from nuclear extracts ( Figure 1F ) shows significantly increased phospho-GSK signal (2.2Ϯ0.18-fold) after incubation with extracts from Akt/nuc expressing cardiomyocytes relative to control cultures expressing nuclearlocalized ␤-gal.
Akt/nuc Does Not Induce Morphological Remodeling Associated With Hypertrophy
Cardiomyocyte cell area measurements were taken to determine whether accumulation of Akt/nuc causes cardiomyocyte enlargement as reported for myristolated Akt (Figure 2 ). Expression of myristolated Akt significantly enlarged cardiomyocytes compared with cells that were uninfected (182%, PՅ0.001) or infected with adenovirus expressing ␤-gal (199%, PՅ0.001), wild-type Akt (218%, PՅ0.001), or Akt/ nuc (194%, PՅ0.001). Akt/nuc showed no increase in cell size compared with uninfected or ␤-gal-expressing cardiomyocytes. Thus, expression of Akt/nuc does not induce hypertrophic remodeling in cultured cardiomyocytes.
Akt/nuc Inhibits Apoptosis Induced by Staurosporine or Deoxyglucose
To determine whether Akt/nuc promotes cell survival in cardiomyocytes, cultured myocardial cells expressing Akt/ nuc were treated either with 1.0 mmol/L deoxyglucose or 0.25 mol/L staurosporine. Apoptotic DNA fragmentation was detected by TUNEL assay. Akt/nuc significantly inhibited apoptosis after treatment with deoxyglucose compared with cells expressing ␤-gal ( Figure 3A ; 82.2Ϯ11.2 versus 46.8Ϯ16.6%; PϽ0.01). Akt/nuc also inhibited apoptosis of staurosporine-treated cells ( Figure 3A ; 78.0Ϯ17.5% versus 40.3Ϯ21.6%; PϽ0.01).
To test whether Akt/nuc prevents apoptosis via downregulation of caspases, we analyzed cleavage of poly ADP-ribose polymerase (PARP), a 116-kDa nuclear DNA repair enzyme substrate of caspase-3 during apoptosis. Cleavage of PARP by caspase-3 yields an 85-kDa fragment, indicating activation of caspases. Cardiomyocyte cultures were infected with Akt/nuc and then treated to induce apoptosis with staurosporine or deoxyglucose the next day. Level of PARP cleavage in Akt/nuc-expressing cells was standardized relative to identically treated cells infected with adenovirus expressing ␤-gal. In the absence of apoptotic stimulation, cleaved PARP signal was decreased 22% in cultures expressing Akt/nuc relative to nuclear-localized ␤-gal ( Figure 3B ). In comparison, Akt/nuc was capable of decreasing PARP cleavage by 55% and 44% in cultures treated with either staurosporine or deoxyglucose, respectively. These reductions of PARP cleavage were highly significant (PϽ0.01), demonstrating that Akt/nuc can inhibit apoptotic activation of caspases.
Akt/nuc Inhibits Apoptosis of Hypoxic Cardiomyocytes
To examine whether Akt/nuc effectively inhibited cardiomyocyte apoptosis as well as constitutively activated (myristolated) Akt, we infected cultured cardiomyocytes with adenovirus encoding either Akt/nuc or myristolated-Akt and the cells were subjected to hypoxia for 24 hours ( Figure 3C 
Generation of Transgenic Mice Cardiac-Specific Expression of Nuclear-Targeted Akt
Transgenic mice expressing nuclear-targeted Akt driven by ␣-myosin heavy chain gene promoter ( Figure 4A ) were created to determine whether Akt/nuc enhances survival of cardiomyocytes in vivo. Expression of Akt/nuc in transgenic mice was confirmed by immunostaining and immunoblot by using Akt and phospho-Akt antibodies ( Figures 4B and 4C ). Transgenic mice (lines 71 and 41) show higher expression of Akt compared with non-transgenic mice. Transgenic Akt/nuc bands show higher apparent mobility because the Akt cDNA is fused with the myc tag and nuclear localization sequence. Transgenic mice were healthy without increases in heart weight/body weight ratio and myocardial cell size compared with nontransgenic mice (data not shown).
Akt/nuc Protects Against Ischemia-Reperfusion Injury
To test whether cardiac-specific transgenic expression of nuclear-targeted Akt was sufficient to protect the heart against pathological damage in vivo, mice were subjected to a 30-minute coronary occlusion followed by 24-hour reperfusion. Myocardial infarct size was significantly reduced in Akt/nuc transgenic mice (5.8% of region at risk, Pϭ0.0009 versus NTG) as compared with nontransgenic controls (21% of region at risk; Figures 4D and 4E) , demonstrating that Akt/nuc protects against ischemia-reperfusion injury.
Akt/nuc Does Not Increase Phosphorylation of Cytoplasmic Akt Substrates
The possibility that Akt/nuc promotes enhanced phosphorylation of cytoplasmic substrates was examined by immunoblot assessment of two canonical targets of activated Akt: GSK-3␤ and BAD. In both cases, phosphorylation levels at residues known to be Akt targets in cardiomyocytes were Full-length wild-type mouse Akt cDNA was cloned upstream of a myc-tag (red) and nuclear localization sequences (NLS, green) and was driven by ␣-myosin heavy chain gene promoter. B, Immunohistochemical study of hearts taken from nontransgenic mice (A, D, and E) and Akt/nuc transgenic mice (B, C, E, and F) simultaneously stained with antibody against total Akt (A, B, and C, green), phospho-Akt (D, E, F, and G, green) and propidium iodide (A through G, red). C, Immunoblot of protein extracted from the nuclear fraction of the mouse heart stained with antibodies against total Akt (top panel) and myc-tag (bottom panel). D, Mice underwent a 30-minute coronary occlusion followed by a 24-hour reperfusion. After postmortem perfusion, the nonischemic portion of the left ventricle was stained blue, the viable tissue within the region at risk bright red, and the infarcted tissue appears light yellow. Representative transverse heart sections from NTG mice (D, left) demonstrate confluent regions of infarction, whereas Akt-nuc transgenic mice (D, right) exhibit only sporadic areas of infarction. E, Graphic representation of myocardial infarct size in NTG mice and nuclear-targeted transgenic mice, expressed as a percentage of the region at risk. ⅙, individual mice; ⅷ, meanϮ SE.
comparable between nontransgenic WT and Akt/nuc transgenic mice ( Figure 5 ). In comparison, phosphorylation levels for GSK-3␤ and BAD were increased in cardiomyocytes isolated from transgenic mice created with cardiac-specific expression of IGF-1, a known stimulus for Akt activation. Similarly, overexpression of myristolated Akt promotes enhanced phosphorylation of GSK-3␤ and BAD, confirming these proteins as substrates for Akt-mediated phosphorylation. These results indicate phosphorylation of typical cytoplasmic target substrates in Akt/nuc transgenic mouse hearts are not increased, supporting the postulate that Akt/nuc is efficiently targeted to the nucleus.
Akt/nuc Does Not Influence Cardiomyocyte Ploidy or DNA Content
The potential for Akt/nuc to promote nuclear division and DNA synthesis was assessed by determination of nuclei per cardiomyocyte and cardiomyocyte DNA content ( Figures 6A  and 6B, respectively) . In both cases, populations of cardiomyocytes isolated from Akt/nuc hearts were comparable to those of nontransgenic WT mice, indicating that expression of Akt/nuc does not promote nuclear replication or DNA synthesis.
Akt/nuc Alters Transcriptional Profile in Transgenic Mouse Hearts
Gene expression in Akt/nuc mouse hearts was compared with normal nontransgenic mice by gene array profiling. Age-and gender-matched hearts were grouped for analysis as samples of pooled Akt/nuc hearts (Tg Aϭ3 hearts, Tg Bϭ4 hearts) and nontransgenic hearts (WT Cϭ3 hearts, WT Dϭ4 hearts). Tg A or Tg B samples were hybridized in quadruplicate (with Cy3 and Cy5 dye reversal) to WT C and in quadruplicate to WT D. Intensity ratio values that differed from the median with a confidence interval Ͼ95% were compiled. The Table  presents nonexpression sequence-tagged (est) genes that were significantly altered in at least three of four hybridizations for each group. For example, Tg A versus WT C showed decreased expression in at least three of four separate hybridizations for prostaglandin D2 synthase (PDGS; lipocalin) and protein tyrosine phosphatase, nonreceptor type 2 (PTP) with increased expression for gastric inhibitory peptide (GIP). PDGS was significantly downregulated in all four groups, and PTP was also downregulated in three of four groups as confirmed by RT-PCR. Although GIP was significantly upregulated in all four groups, GIP was not detectable in Akt/nuc heart RNA using RT-PCR suggesting crosshybridization occurred with another mRNA possessing a similar coding sequence. Four additional genes were differentially regulated in one of the four groups (not shown). Subsequent RT-PCR validation tests confirmed one of these genes, connective tissue growth factor (CTGF), was downregulated in three of the four comparison groups. 
Fold Change in Gene Expression Determined by Microarray and Confirmed by RT-PCR
Discussion
Akt myocardial biology involving overexpression has been studied with constitutively activated 26, 27, 29, 30, 38, 39 or dominantnegative kinase. 38 Characterizing Akt activation in the myocardium produces two recurring themes: promotion of growth and antiapoptotic activity. Promotion of growth is observed in vivo, particularly in assessment of postnatal cardiac enlargement resulting from transgenic expression of Akt kinase in the myocardium, 38 -40 although hypertrophic growth of cardiomyocytes was also reported. 36 Antiapoptotic effects are a consistent finding both in vivo 26, 29 and in vitro. 26, 27 Alternatively, myocardial Akt signaling has been examined through manipulation of insulin 41 or IGF-1 stimulation. 31, 42 Shared phenotypic characteristics of apoptotic resistance and hypercellularity were observed after cardiac-specific overexpression of IGF-1 43 or constitutive Akt activation. 38 -40 However, other aspects of Aktoverexpression showing hypertrophy, 38 -40 depressed contractile function, 38 -40 and heart failure 39 are not readily reconciled with the phenotype of IGF-1 overexpressing transgenics. One potential explanation for the phenotypic differences between constitutively activated Akt-versus IGF-1 overexpression in the heart may be the degree and distribution of Akt activity, prompting our investigation of the consequences for targeted activation of Akt in the nucleus of cardiomyocytes.
Hearts from IGF-1-overexpressing mice show accumulation of activated Akt in the nucleus compared with nontransgenic mice, which show differential nuclear Akt activity correlating with gender. 31 Akt does not possess an inherent nuclear localization signal sequence and activated Akt may depend on cofactors such as TCL1 that mediate nuclear localization by facilitating Akt oligomerization. 44, 45 TCL1 is an oncogene of human T-cell leukemia, but related molecules responsible for nuclear translocation of Akt may exist in cardiomyocytes. Numerous cell survival and cell cycle transcription factor substrates for Akt phosphorylation are located in the nucleus, including forkhead family proteins, 9,10 SRK, 13 E2F, 14 CREB, 15 TSC2, 46 p21Cip/WAF1, 47 and telomerase reverse transcriptase. 48 In fact, Akt/nuc enhances telomerase activity and antagonizes the phenotypic changes characteristic of cardiomyocyte aging and senescence much better than wild-type Akt (unpublished results, 2004 ). Studies to determine the ability of cardiac-specific expression of Akt/nuc to antagonize aging in the myocardium are in progress and thus far Akt/nuc expression in transgenic mice to over 1 year of age does not provoke overt cardiomyopathic effects.
Activated Akt in cardiomyocytes localizes to the nucleus and estrogenic stimulation increased nuclear accumulation of activated Akt as well as cytoplasmic localization of forkhead transcription factors. 31 Although Akt/nuc successfully promotes cell survival, the expression of cellular Akt (nonactivated form) in a previous study did not inhibit apoptosis without stimulation of IGF-1. 26 In comparison, the subcellular distribution of constitutively active Akt is dispersed among the cellular components with 40% on the cell membranes, 30% in the nucleus, and 30% in the cytosol, whereas overexpression of cellular wild-type Akt accumulates primarily (90%) in the cytosol. 33 Furthermore, Akt/nuc inhibited hypoxia-induced apoptosis as efficiently as (or better than) myristolated Akt. However, phosphorylation of cytoplasmic targets including the apoptotic mediator BAD were unchanged in Akt/nuc transgenic hearts ( Figure 5 ). These findings support our postulate that relevant targets for Akt phosphorylation that mediate cellular survival are present in nucleus.
Potent antiapoptotic effects of Akt/nuc meet and surpass the level of protection afforded by Akt/myr both in vitro and in vivo (Figures 3 and 4) . Cardiac-specific transgenesis of nuclear-targeted Akt produced a profound infarct-sparing effect (Ϸ70% reduction versus wild type). Akt/nuc affords protection comparable in magnitude to early ischemic preconditioning (Ϸ75% reduction), 49 the most powerful cardioprotective modality that has been described to date.
Two genes found to be downregulated in Akt/nuc transgenic hearts are PGDS and PTP, which are novel and distinct from genes previously reported to be influenced by expression of activated Akt in the myocardium. 50 Estrogen has been reported to increase PGDS mRNA in rat brain, 51 and we previously found estrogen increases nuclear localization of Akt. 31 Complex regulation of estrogen of PGDS 51 and significant differences in experimental design could account for decreased PDGS expression in our study versus increased estrogen-mediated expression in the brain. Thus, PGDS may be an interesting estrogen-regulated gene in the heart. PTPN2 (also known as TC-PTP) is homologous to PTP-1B. 52 PTP-1B influences PI3-kinase, 53 insulin-mediated signaling, 54, 55 and downregulation enhances IGF-1-mediated cell survival. 56, 57 Thus, decreased expression of PTP could help promote enhanced cardiomyocyte survival in Akt/nuc transgenic mice.
Ideally, therapeutic intervention in apoptotic cardiomyocyte death should exert minimal deleterious effects on cardiomyocyte structure or function. Experimental prevention of cell death in acute cardiac injury associated with apoptosis has been attempted using membrane-targeted myristolated Akt, 26 -30 but supraphysiological levels of constitutively activated kinase 34, 35 cause cardiomyocyte hypertrophy 36, 38 and cardiomyopathic effects. 38, 39 Potent survival signaling without promoting hypertrophic remodeling or DNA synthesis makes Akt/nuc an interesting candidate for therapeutic intervention against cardiomyopathic injuries resulting from ischemic heart disease, chronic pressure or volume overload, hypoxia, or anticancer drugs.
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Experimental Procedures
Adenovirus expressing Akt with nuclear localization signals. Adenovirus expressing mouse cellular Akt with nuclear localization signals (Akt/nuc) was created by PCR-based cloning technique using mouse cellular Akt as a template. The PCR product was subcloned into pShooter Vector plasmid (pCMV/myc/nuc, Invitrogen), which has myc and triplet nuclear localization signals at the 3'-end of the multiple cloning sites (Fig. 1A) . The resultant product was subcloned into adenovirus shuttle vector pDC315 (Microbix) for use with the AdEasy Cremediated site-specific recombination system. Immunohistochemistry and confocal microscopy. Immunostaining and confocal microscopy were performed as previously described. 3 Antibodies were obtained to detect total Akt (Cell Signaling Technologies), phospho-Akt (Biosource), and α-actinin (Sigma).
95% N 2 /5% CO 2 , and cells were placed in a 37 o C airtight box saturated with 95% N2/5% CO 2 for 24 hours. O 2 concentrations were <0.1% (Ohmeda oxygen monitor, type 5120). For normoxic controls, culture medium was changed to RPMI1640/5% FCS/10% HS, and cells were placed in 
DNA fragmentation.
In vitro model of cardiomyocytes hypoxia and DNA fragmentation assay was performed as previously described. Mouse model of myocardial infarction. The mouse model of myocardial infarction has been previously described in detail. 6, 7 Briefly, myocardial infarction was produced by a 30- at 4-6 weeks of age. 8 Hearts were excised and left ventricular (LV) myocytes were enzymatically dissociated. 8 Briefly, the heart was connected to a plastic cannula for retrograde Table 1 .
First strand synthesis was conducted for 60 min at 48°C in a 10-µl reaction containing 100 ng total RNA, 5.5 mM MgCl2, 2 µM dNTPs, 4 units RNase inhibitor, and 12.5 units reverse transcriptase. The real-time PCR reaction was carried out in a total volume of 40 µl which included the first strand synthesis reaction to which was added 4 mM MgCl2, 8 mM dNTPs, 1X
SYBR green PCR buffer (PE Biosystems), 0.4 µM gene specific primers, and 2.5 units AmpliTaq Gold DNA polymerase (PE Biosystems). The reaction was analyzed using an 
